Pages
Vote for naming Bakewell’s new NHS health hub
https://dchs.nhs.uk/news/vote-naming-bakewells-new-nhs-health-hub
800,000 people, 1.8 million jabs
One year of the Covid-19 vaccination programme in Derbyshire.
Lovely 'shout-out' for Katrina Roberts
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/lovely-shout-out-katrina-roberts
Sign up for updates - volunteers
https://dchs.nhs.uk/join-us/volunteer-with-us/sign-updates-volunteers
The DCHS Admin People’s Charter 2024
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/dchs-admin-peoples-charter-2024
Health leaders invite you to join their regular Board meeting
https://dchs.nhs.uk/news/health-leaders-invite-you-join-their-regular-board-meeting
Metal shell of new NHS facility in Chesterfield takes shape ahead of installation
https://dchs.nhs.uk/news/metal-shell-new-nhs-facility-chesterfield-takes-shape-ahead-installation
Files
Guidance for Wound Clinic Services for the use of tap water on chronic wounds (G308)
Guidance for Wound Clinic Services for the use of tap water on chronic wounds
L313 - Anticipatory Medicines and Syringe Drivers (Inpatients) Leaflet
L313 - Anticipatory Medicines and Syringe Drivers (Inpatients) Leaflet
DCHS Scheme Of Delegation
Scheme Of Delegation - April 2025
A2 - Catheter Clinical Appointment Letter (G324)
Catheter Clinical Appointment Letter
Disclosure Ref 2024131 - Cyber Security Attacks.pdf
FOI Disclosure relating to Cyber Security Attacks
Disclosure Ref 2024124 - Sub Contracting of Online Online Sexual Health Services.pdf
Disclosure Ref 2024124 - Sub Contracting of Online Online Sexual Health Services
Disclosure Ref 2024134 - Self Declaration July 2021.pdf
Disclosure Ref 2024134 - Self Declaration July 2021
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010
A1 - Observational Audit - protected meal times (G50)
Observational Audit - protected meal times
Integrated Performance Report - November 2024
Integrated Performance Report - November 2024